XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.62+0.08 (+5.19%)
Close on Nov 17, 2026Market cap $15.33MP/E –Yield –
XTL Biopharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
XTL Biopharmaceuticals's pe ratio was 8.9× on Feb 28, 2020.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Feb 28, 2020 | 8.9× | −0.2 |
| 2019 | Dec 31, 2019 | 9.1× | – |
See a number that looks wrong?